PharmaCyte Biotech announces publication of U.S. patent application for cancer therapies.
Source: www.businesswire.com
PharmaCyte Biotech Inc, has announced the publication of its patent application titled “Encapsulated Cells Producing Cytochrome P450 and Methods of Use Thereof,” which covers a targeted therapy to treat solid cancerous tumors, in the United States on September 27, 2018. This patent application is specific to the United States, unlike the previous PCT application which was international in nature. PharmaCyte Biotech Inc, is a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®,
